Skip to main content
Clinical Trials/NL-OMON43548
NL-OMON43548
Completed
Phase 2

Improved screening of esophageal cancer by optical detection of field cancerization. - SPECTRE

Academisch Medisch Centrum0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
1. Malignant cells in Barretts esophagus. 2. Field carcinogenesis.
Sponsor
Academisch Medisch Centrum
Enrollment
60
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Patients referred for endoscopic treatment of early neoplasia in a Barrett\*s esophagus or patients undergoing standard endoscopic surveillance for non\-dysplastic Barrett\*s esophagus.
  • \- Age \> 18 years.
  • \- Signed informed consent.

Exclusion Criteria

  • \- Contraindications for ER and/or obtain biopsies (e.g. due to anticoagulation, coagulation disorders, esophageal varices).
  • \- Presence of an advanced lesion (e.g. type 0\-I or type 0\-III) not amendable for endoscopic resection (T1b).
  • \- Presence of erosive esophagitis (Los Angeles classification \>\=A).
  • \- Unable to provide signed informed consent.

Outcomes

Primary Outcomes

Not specified

Similar Trials